Next-generation Sequencing Global Markets to reach $10.5 billion by 2022 at a compound annual growth rate (CAGR) of 27% From 2018-2022

Press Release – 11 Jan 2019
Research and Development News --
. .
Latest Update "Next-generation Sequencing: Emerging Clinical Applications and Global Markets Update 2018" with Industries Survey | Global Current Growth and Future.
' '
Report Includes
- An overview of the global market for next-generation sequencing and its emerging clinical applications
- Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018
(The next generation sequencing market reached $231.7 million in 2012. The market is expected to reach $510.7 million in 2013 and $7.6 billion in 2018 for a compound annual growth rate (CAGR) of 71.6%.)
- Examination of the sequencing industry structure for the key market segments, as well as strategic alliances and acquisitions, as well as evaluations of sequencing patents
- Discussion of the strategies of the main companies in the market
- Comprehensive company profiles of major players in the field
. .
– Get Sample Report_ https://www.researchmoz.us/enquiry.php?type=S&repid=1377182
' '
The global clinical next-generation sequencing (NGS) market reached $2.7 billion in 2016. This market is expected to grow at a compound annual growth rate (CAGR) of 27%, from nearly $3.2 billion in 2017 to $10.5 billion by 2022.
Report Scope
The scope of the report includes clinical NGS technologies, applications, industries, initiatives, patents and companies.  The markets for NGS-based diagnostics are given for the years 2012, 2013 and 2018.

This report reviews the main sequencing technologies and explains why genetic variation is important in clinical testing.  It then discusses some of the top research initiatives that are contributing to clinical NGS applications.  Market driving forces are also discussed.

The report examines the markets by test complexity, indication and test purpose.  Test complexity refers to the multiplexing (e.g., the number of genes covered) and coverage (e.g., the extent to which the genome is covered) of the test.  Examining the market by test complexity provides valuable insight into which products (e.g., sample preparation, NGS instrument, informatics) will be in demand in the future.

(Non-cancer applications as a segment should reach $2.3 billion in 2017 to $6.4 billion by 2020, at a CAGR of 22.3% from 2017 to 2022.)
. .
– For Other Requirement and Enquiry_ https://www.researchmoz.us/enquiry.php?type=E&repid=1377182
' '
The report provides market data and forecasts for NGS diagnostics by specific applications, including those for cancer, rare diseases, common diseases, and pre- and post-natal screening.
- Specific geographic markets are discussed, including North America, Europe, China, Japan and the rest of the world.
- Market data covers the years 2012, 2013 and 2018.
- Industry sectors analyzed include NGS instruments, target enrichment, informatics, clinical laboratories and the prenatal screening industry.
- More than 110 companies in the clinical NGS industry are profiled in this report.
- BCC Research provides a summary of the main industry acquisitions and strategic alliances from 2011 through 2013, including key alliance trends.

(Cancer applications as a segment should reach $838.8 million in 2017 to nearly $4.1 billion by 2022, at a CAGR of 37.3% from 2017 to 2022)

Continue.....
– More Clear Details get Full Table of Contents_ https://www.researchmoz.us/next-generation-sequencing-emerging-clinical-applications-and-global-markets-report.html/toc

About Researchmoz,

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Researchmoz Global Pvt. Ltd.
90 State Street,
Albany, NY 12207,
United States,
www.researchmoz.us
Tel: 866-997-4948 (Us-Canada Toll Free),
Tel: +1-518-621-2074

This release was published on openPR.